Short-term efficacy and safety of lurasidone versus placebo in antipsychotic-naïve versus previously treated adolescents with an acute exacerbation of schizophrenia

BACKGROUND: To evaluate the efficacy of short-term lurasidone in antipsychotic treatment-naïve (TN) adolescents with schizophrenia versus those treated previously (TP) with antipsychotics. METHODS: Patients aged 13–17 with schizophrenia, and a Positive and Negative Symptom Scale (PANSS) score ≥ 70 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Correll, Christoph U., Tocco, Michael, Hsu, Jay, Goldman, Robert, Pikalov, Andrei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058440/
https://www.ncbi.nlm.nih.gov/pubmed/35322769
http://dx.doi.org/10.1192/j.eurpsy.2022.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058440/
https://www.ncbi.nlm.nih.gov/pubmed/35322769
http://dx.doi.org/10.1192/j.eurpsy.2022.11

Ejemplares similares